Ajuji, Bb Boy .
HRN: 22-54-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2023
AMPICILLIN 250MG (VIAL)
01/22/2023
01/29/2023
IV
140 Mg
Q12
PSNB 2 To MSAF Thickly
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes